Approval for the addition of the antibiotic tobramycin to the Vitek(R) 2 Gram Negative Susceptibility Test System.  The device, as modified, will be marketed under the trade name Vitek(R) 2 and is indicated for use in the Vitek(R) 2 gram negative susceptibility panel for the susceptibility testing of gram negative isolates to tobramycin in the range of <1 to >16 ug/ml.